» Articles » PMID: 19578433

The Dynamics of EBV Shedding Implicate a Central Role for Epithelial Cells in Amplifying Viral Output

Overview
Journal PLoS Pathog
Specialty Microbiology
Date 2009 Jul 7
PMID 19578433
Citations 139
Authors
Affiliations
Soon will be listed here.
Abstract

To develop more detailed models of EBV persistence we have studied the dynamics of virus shedding in healthy carriers. We demonstrate that EBV shedding into saliva is continuous and rapid such that the virus level is replaced in < or =2 minutes, the average time that a normal individual swallows. Thus, the mouth is not a reservoir of virus but a conduit through which a continuous flow stream of virus passes in saliva. Consequently, virus is being shed at a much higher rate than previously thought, a level too high to be accounted for by replication in B cells in Waldeyer's ring alone. Virus shedding is relatively stable over short periods (hours-days) but varies through 3.5 to 5.5 logs over longer periods, a degree of variation that also cannot be accounted for solely by replication in B cells. This variation means, contrary to what is generally believed, that the definition of high and low shedder is not so much a function of variation between individuals but within individuals over time. The dynamics of shedding describe a process governing virus production that is occurring independently < or =3 times at any moment. This process grows exponentially and is then randomly terminated. We propose that these dynamics are best explained by a model where single B cells sporadically release virus that infects anywhere from 1 to 5 epithelial cells. This infection spreads at a constant exponential rate and is terminated randomly, resulting in infected plaques of epithelial cells ranging in size from 1 to 10(5) cells. At any one time there are a very small number (< or =3) of plaques. We suggest that the final size of these plaques is a function of the rate of infectious spread within the lymphoepithelium which may be governed by the structural complexity of the tissue but is ultimately limited by the immune response.

Citing Articles

A large-scale population-based study reveals that gp42-IgG antibody is protective against EBV-associated nasopharyngeal carcinoma.

Kong X, Bu G, Chen H, Huang Y, Liu Z, Kang Y J Clin Invest. 2024; 135(4).

PMID: 39589824 PMC: 11827846. DOI: 10.1172/JCI180216.


Highly Heterogeneous Kaposi Sarcoma-Associated Herpesvirus Oral Shedding Kinetics Among People With and Without Kaposi Sarcoma and Human Immunodeficiency Virus Coinfection.

Krantz E, Mutyaba I, Nankoma J, Okuku F, Casper C, Orem J Open Forum Infect Dis. 2024; 11(10):ofae548.

PMID: 39371366 PMC: 11450676. DOI: 10.1093/ofid/ofae548.


EBV + B cell-derived exosomes promote EBV-associated T/NK-cell lymphoproliferative disease immune evasion by STAT3/IL-10/PD-L1 pathway.

Chen W, Xie Y, Li F, Wen P, Wang L Immunol Res. 2024; 72(6):1327-1336.

PMID: 39164446 PMC: 11618311. DOI: 10.1007/s12026-024-09531-3.


Detection of Epstein‒Barr virus DNA methylation as tumor markers of nasopharyngeal carcinoma patients in saliva, oropharyngeal swab, oral swab, and mouthwash.

Zheng X, Li X, Tang C, Zhang Y, Zhou T, Yang X MedComm (2020). 2024; 5(9):e673.

PMID: 39161799 PMC: 11331033. DOI: 10.1002/mco2.673.


Cytokine Storm Syndromes Associated with Epstein-Barr Virus.

Verbist K, Nichols K Adv Exp Med Biol. 2024; 1448:227-248.

PMID: 39117818 DOI: 10.1007/978-3-031-59815-9_16.


References
1.
Ling P, Lednicky J, Keitel W, Poston D, White Z, Peng R . The dynamics of herpesvirus and polyomavirus reactivation and shedding in healthy adults: a 14-month longitudinal study. J Infect Dis. 2003; 187(10):1571-80. DOI: 10.1086/374739. View

2.
Niederman J . Infectious mononucleosis: observations on transmission. Yale J Biol Med. 1982; 55(3-4):259-64. PMC: 2596461. View

3.
Miller C, Lee J, Kieff E, Longnecker R . An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking. Proc Natl Acad Sci U S A. 1994; 91(2):772-6. PMC: 43031. DOI: 10.1073/pnas.91.2.772. View

4.
Chang S, Lo Y, Chua H, Chiu H, Tsai S, Chen J . Critical role of p53 in histone deacetylase inhibitor-induced Epstein-Barr virus Zta expression. J Virol. 2008; 82(15):7745-51. PMC: 2493335. DOI: 10.1128/JVI.02717-07. View

5.
Pegtel D, Middeldorp J, Thorley-Lawson D . Epstein-Barr virus infection in ex vivo tonsil epithelial cell cultures of asymptomatic carriers. J Virol. 2004; 78(22):12613-24. PMC: 525079. DOI: 10.1128/JVI.78.22.12613-12624.2004. View